Skip to main content

Catheter Precision, Inc.

VTAK
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001716621

No open-market purchases or sales by Catheter Precision, Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $57.2K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Catheter Precision, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Catheter Precision, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Catheter Precision, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Colombatto Martin JDirector0IndirectMar 30, 20261
Jenkins David AChairman of the Board and CEO109IndirectMar 30, 20264
Anderson Philip JChief Financial Officer–Mar 30, 20261
Caruso James JosephDirector50Mar 30, 20262
Arno AndrewDirector–Mar 30, 20261
Jacques Marie-ClaudeChief Commercial Officer–Jan 31, 20250
Francis, John P.Director–Jan 10, 20240
Thomassen MargritInterim CFO and Secretary–Jan 10, 20240
Meline SusanneDirector2,575IndirectMar 27, 20230
McGuire Jonathan WillCEO & Secretary1,083Mar 15, 20230
Jackson Andrew C.CFO21,680May 24, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 31, 2025 (view filing)4:39 PM ETJan 292 daysColombatto Martin JDirectorSSale−3$0.40−$1.2−100.0%0 after
Jan 24, 2024 (view filing)4:15 PM ETJan 22-232 daysJenkins David AExecutive Chairman and CEOPPurchase+19.1K$0.5136+$9.79K+6.1%329.9K after2 lots
Jan 22, 2024 (view filing)4:15 PM ETJan 18-194 daysJenkins David AExecutive Chairman and CEOPPurchase+16.9K$0.4183+$7.09K+5.8%310.8K after2 lots
Jan 18, 2024 (view filing)4:15 PM ETJan 162 daysJenkins David AExecutive Chairman and CEOPPurchase+16.3K$0.3888+$6.32K+5.9%293.9K after2 lots
Nov 24, 2021 (view filing)Nov 222 daysJackson Andrew C.CFOSSale−2.68K$2.62−$7.03K−10.4%23.0K after
Nov 24, 2021 (view filing)Nov 222 daysMcGuire Jonathan WillChief Executive OfficerSSale−8.15K$2.62−$21.4K−10.9%66.7K after